Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study

Muhammad Arif, Eva Coopmans, Patric Delhanty, Alof Dallenga, Iain Haitsma, J.A.M.J.L. Janssen, AJ (Aart-Jan) van der Lely, S.J.C.M.M. Neggers

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)269-277
Number of pages9
JournalEuropean Journal of Endocrinology
Issue number5
Publication statusPublished - 2018

Cite this